The Pediatric Impact of the Opioid Crisis: Session 1 of 4
The Poison Control Center’s Opioid Assistance Resource (OAR) line is organizing a 4-part virtual webinar series focusing on prescribing, family and pediatric approaches to opioid use disorder (OUD) care, and the landscape of substance and opioid treatment in Philadelphia.
This series is part of the OAR Line collection with support from the Health Federation of Philadelphia's Substance Use Response Guidance and Education (SURGE) program
Session #1: Wednesday, August 31, 2022 from 8:00 am - 9:00 am. Online.
This session will explore the many ways in which opioid epidemic affects pediatric medicine, from toddler exploratory poisonings, to young patients’ parental loss, neonatal abstinence syndrome to adolescent opioid use disorder. The program will look at child injury epidemiology and focus on child injury prevention. Attendees will learn how they can reduce the harm of the opioid epidemic by sharing key public health messages with caretakers of pediatric patients.
Registration: https://www.eventbrite.com/e/372177000427
Cost: None
Target Audience: This program is designed for Physicians, Nurse Practitioners (NPs), Physician Assistants (PAs), Clinical Nurse Specialists (CNSs), Certified Registered Nurse Anesthetist (CRNAs), and Certified Nurse-Midwifes (CNMs) able to obtain an X waiver from SAMHSA to prescribe buprenorphine and their care team colleagues.
Moderator: Robert Bassett, DO – Associate Medical Director, Poison Control Center
Introduction: Rachel Linstead Goldsmith, MPA – Comprehensive Opioid Response and Education (CORE) Program Coordinator
Presenter: Dr. Kevin Osterhoudt, MD, MSCE, FAAP, FACMT
- Dr. Osterhoudt is an attending physician in the Division of Emergency Medicine, and the medical director of the Poison Control Center, at the Children's Hospital of Philadelphia (CHOP) and is Professor of Pediatrics at the University of Pennsylvania School of Medicine. Dr. Osterhoudt is an Associate Fellow for the Center for Injury Prevention and Research at CHOP and is a member of the Executive Committee of the American Academy of Pediatrics’ Council on Injury, Violence and Poisoning Prevention.
Learning Objectives: Upon completion of this live activity, participants will be able to:
- Discuss clinical and social outcomes of the opioid epidemic that impact pediatric medicine
- Identify harm reduction parenting strategies to share with caretakers of minor patients
About the OAR Line:
Philadelphia’s Opioid Assistance Resource (OAR) line at 267-426-5900 offers 24/7 support to clinicians who are new to buprenorphine initiation and management as well as those seeking consultation for complex cases. Operated by the Poison Control Center at CHOP and funded in part by the City of Philadelphia, OAR line guidance is provided by medical professionals with expertise in the management of opioid toxicity and withdrawal.
Accreditation Statement: The Children's Hospital of Philadelphia is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation Statement: The Children's Hospital of Philadelphia designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure Statement: Kevin Osterhoudt, MD, MS and Robert Bassett, DO (speakers), Jeanette Trella, PharmD and Lauren Longo, MPH (course directors), and Joan Nolan, RN, Rachel Linstead Goldsmith, MPA and Tina Mannices (CME Planners) have no relevant financial relationship with an ineligible company to disclose.
Supported in part by the Philadelphia Department of Public Health